Strontium ranelate causes osteophytes overgrowth in a model of early phase osteoarthritis

BACKGROUND: Osteoarthritis (OA) involves cartilage changes as well as modifications of subchondral bone and synovial tissues. Strontium ranelate (SR), an anti-osteoporosis compound, which is currently in phase III clinical trial for treatment of OA. Evidences suggest that SR preferably deposited in...

Descripción completa

Detalles Bibliográficos
Autores principales: Chu, Jian-Guo, Dai, Mu-Wei, Wang, Yu, Tian, Fa-Ming, Song, Hui-Ping, Xiao, Ya-Ping, Shao, Li-Tao, Zhang, Ying-Ze, Zhang, Liu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5303224/
https://www.ncbi.nlm.nih.gov/pubmed/28187731
http://dx.doi.org/10.1186/s12891-017-1399-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5303224/
https://www.ncbi.nlm.nih.gov/pubmed/28187731
http://dx.doi.org/10.1186/s12891-017-1399-2

Ejemplares similares